Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28c7020fa0274dcb74c61b1cf8a2ba17 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- |
filingDate |
2004-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd863be68362c0460daa973d08acdc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9719c8ed8fe3d5c09d33a12ede24f67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4268daa99792293ffb1bff1b4db8423d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ed496b01899f3a4484587f507b5061 |
publicationDate |
2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2330678-C2 |
titleOfInvention |
Compositions and methods of breast cancer treatment with morinda citrifolia and methylsulphonylmethane |
abstract |
FIELD: medicine; pharmacology. n SUBSTANCE: invention concerns composition for treatment, inhibition and prevention of breast cancer containing: one of the processed products and extracts Morinda Citrifolia, in amount five percent by mass; and methylsulphonylmethane in amount five percent by mass. Also application of processed Morinda Citrifolia in manufacturing of composition for treatment, inhibition and prevention of breast cancer and application of processed Morinda Citrifolia in manufacturing of medicinal composition chemically preventing and inhibiting carcinogenesis at initiative stage of carcinogen chemical blocking, free radicals isolation, lipid peroxides suppression and COX-2 inhibition are discovered. n EFFECT: offered composition has synergetic effect. n 18 cl, 5 dwg, 5 ex |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524012-B1 |
priorityDate |
2003-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |